Edition:
United States

Key Developments: ICU Medical Inc (ICUI.OQ)

ICUI.OQ on NASDAQ Stock Exchange Global Select Market

104.03USD
27 May 2016
Change (% chg)

$1.28 (+1.25%)
Prev Close
$102.75
Open
$102.49
Day's High
$104.85
Day's Low
$102.49
Volume
25,214
Avg. Vol
57,489
52-wk High
$123.65
52-wk Low
$85.72

Latest Key Developments (Source: Significant Developments)

ICU Medical Q1 GAAP earnings per share $0.96
Tuesday, 10 May 2016 04:05pm EDT 

ICU Medical Inc : Q1 adjusted earnings per share $1.14 . Q1 gaap earnings per share $0.96 . Q1 revenue $89.9 million versus I/B/E/S view $88 million . Sees fy 2016 adjusted earnings per share $4.34 to $4.46 . Sees fy 2016 revenue $355 million to $365 million . Q1 earnings per share view $1.01 -- Thomson Reuters I/B/E/S . Reiterating its 2016 guidance .Fy2016 earnings per share view $4.41, revenue view $362.3 million -- Thomson Reuters I/B/E/S.  Full Article

ICU Medical Inc gives FY 2016 outlook
Wednesday, 3 Feb 2016 04:10pm EST 

ICU Medical Inc:Says for FY 2016 , expects revenue to be in the range of $355 million to $365 million; adjusted diluted earnings per share to be in the range of $4.34 to $4.46, and adjusted EBITDA to be in the range of $123 million to $127 million.  Full Article

ICU Medical Inc board authorizes close of Slovakia manufacturing facility
Wednesday, 18 Nov 2015 07:40pm EST 

ICU Medical Inc:Says on November 16, board authorized company to close its vrable, Slovakia manufacturing facility.Says pre-tax charges are expected to be recorded primarily during the fourth quarter of 2015.Slovakia facility closure will result in a pre-tax restructuring charge to earnings of approximately $3.4 million.Says Slovakia facility closure will impact approximately 265 employees.Estimates that Slovakia facility closure will result in a pre-tax restructuring charge to earnings of approximately $3.4 million.Net cash outlays related to actions expected to be about $3.3 million to $5.7 million.Substantially all of net cash outlays related to actions expected to be paid during fiscal 2016.  Full Article

ICU Medical partners with Medline Industries to acquire Excelsior Medical; signed agreement to sell operating assets of SwabFlush and pre-filled saline and heparin flush syringes to Medline Industries
Monday, 5 Oct 2015 04:10pm EDT 

ICU Medical:Says signing of a definitive agreement to acquire Excelsior Medical Corporation, a manufacturer of healthcare devices used to disinfect and protect access into a patient's bloodstream.Excelsior has developed and commercialized the innovative SwabCap and SwabFlush products and is a leader in pre-filled saline and heparin flush syringes.Excelsior is owned by RoundTable Healthcare Partners, an operating-oriented private equity firm focused exclusively on the healthcare industry.ICU Medical's purchase price for Excelsior is $59.5 million.ICU also signed a definitive agreement to sell the operating assets of SwabFlush and the pre-filled saline and heparin flush syringes to Medline Industries, Inc. for $27 million.Transaction with Medline will close immediately following the acquisition by ICU Medical of Excelsior.The transaction will be funded with cash on hand and is expected to be neutral to earnings in 2015.  Full Article

ICU Medical Inc raises FY 2015 outlook
Monday, 10 Aug 2015 04:02pm EDT 

ICU Medical Inc:Expects FY 2015 revenue to be in the range of $325 to $330 million, compared to the previous range of $312 to $317 million.Expects FY 2015 GAAP diluted earnings per share to be in the range of $2.63 to $2.83, compared to the previous range of $2.15 to $2.25.Expects FY 2015 adjusted diluted earnings per share to be in the range of $3.49 to $3.69, compared to the previous range of $2.70 to $2.80.Expects FY 2015 adjusted EBITDA to be in the range of $100 million to $105 million, compared to the previous range of $84 million to $86 million.FY 2015 revenue of $319 million, EBITDA of $91 million and EPS of $3.14 - Thomson Reuters I/B/E/S.  Full Article

ICU Medical Inc gives FY 2015 EPS guidance; revenue and EBITDA guidance above analysts' estimates
Monday, 9 Feb 2015 04:05pm EST 

ICU Medical Inc:Expects FY 2015 revenue to be in the range of $312 million to $317 million.Expects FY 2015 GAAP diluted earnings per share to be in the range of $2.15 to $2.25.Expects FY 2015 adjusted diluted earnings per share to be in the range of $2.70 to $2.80.Expects FY 2015 adjusted EBITDA to be in the range of $84 million to $86 million.FY 2015 revenue of $308 million, EBITDA of $81 million and EPS of $2.76 - Thomson Reuters I/B/E/S.  Full Article

ICU Medical Inc raises FY 2014 guidance
Monday, 10 Nov 2014 04:05pm EST 

ICU Medical Inc:Expects FY 2014 revenue to be in the range of $304 million to $307 million, compared to the previous range of $285 million to $300 million.Expects FY 2014 GAAP diluted earnings per share increased to a range of $1.62 to $1.70 compared to the previous range of $1.30 to $1.45.Expects FY 2014 Adjusted diluted earnings per share increased to a range of $2.25 to $2.33 compared to the previous range of $1.95 to $2.15.Expects FY 2014 Adjusted EBITDA is increased to a range of $69 million to $71 million compared to the previous range of $63 million to $68 million.FY 2014 revenue of $ 297 mln, EPS of $2.06 and EBITDA of $ 66 - Thomson Reuters I/B/E/S.  Full Article

ICU Medical, Inc lowers FY 2014 EPS guidance; raises FY 2014 EBITDA guidance
Monday, 11 Aug 2014 04:05pm EDT 

ICU Medical, Inc:Increases FY 2014 GAAP diluted earnings per share to a range of $1.30 to $1.50 compared to the previous range of $1.15 to $1.45.Expects FY 2014 adjusted diluted earnings per share is in the range of $1.95 to $2.15.Increases FY 2014 adjusted EBITDA range to $63 million to $68 million compared to the previous range $58 million to $65 million.FY 2014 EBITDA of $56 million - Thomson Reuters I/B/E/S.  Full Article

BRIEF-ICU Medical Q1 GAAP earnings per share $0.96

* Q1 earnings per share view $1.01 -- Thomson Reuters I/B/E/S